Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients

Journal of Functional Foods

Volumn 5, Issue 3, 2013, Pages 1366-1371

  Vertolli, Ugo ^a   Davis, Paul A ^b   Maso, Lucia Dal ^a   Maiolino, Giuseppe ^a   Naso, Agostino ^a   Plebani, Mario ^a   Calò, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dialysis; FDP D Dimer; Fibrinogen; Green tea; Inflammation; Oxidative stress

Indexed keywords

EID: 84880506154     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.05.004     Document Type: Article

References (32)

1. Antonello M., Montemurro D., Bolognesi M., Di Pascoli M., Piva A., Grego F., Sticchi D., Giuliani L., Garbisa S., Rossi G.P. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. American Journal of Hypertension 2007, 20:1321-1328.
2. Babior B.M. NADPH oxidase: An update. Blood 1999, 93:1464-1476.
3. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea-a review. Journal of the American College of Nutrition 2006, 25:79-99.
4. Calò L.A., Naso A., Carraro G., Wratten M.L., Pagnin E., Bertipaglia L., Rebeschini M., Davis P.A., Piccoli A., Cascone C. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrology Dialysis and Transplantation 2007, 22:1413-1419.
5. Calò L.A., Naso A., D'Angelo A., Pagnin E., Zanardo M., Puato M., Rebeschini M., Landini S., Feriani M., Perego A., Malagoli A., Zagatti R., Calzavara P., Cascone C., Davis P.A. Molecular biology-based assessment of vitamin E-coated dialyzer effects on oxidative stress, inflammation, and vascular remodeling. Artificial Organs 2011, 35:E33-E39.
6. Calò L.A., Naso A., Davis P.A., Pagnin E., Corradini R., Tommasi A., Sereni L., Ragazzi E. Hemodiafiltration with on-line regeneration of ultrafiltrate: effect on HO-1 and iNOS and implication for oxidative stress and inflammation. Artificial Organs 2011, 35:183-187.
7. De Filippis V., Lancellotti S., Maset F., Spolaore B., Pozzi N., Gambaro G., Oggianu L., Calò L.A., De Cristofaro R. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure. Biochemical Journal 2012, 442:423-432.
8. Dhalla N.S., Temsha R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 2000, 18:655-673.
9. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of literature. Annals of Internal Medicine 1993, 118:956-963.
10. Fernandez P.L., Martin M.J., Gonzalez A.G., Pablos F. HPLC determination of catechins and caffeine in tea. Differentiation of green, black and instant teas. Analyst 2000, 125:421-425.
11. Fried L.F., Shlipak M.G., Crump C., Bleyer A.J., Gottdiener J.S., Kronmal R.A., Kuller L.H., Newman A.B. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. Journal of the American College of Cardiology 2003, 41:1364-1372.
12. Griendling K.K., Soresen D., Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circulation Research 2000, 86:494-501.
13. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. American Journal of Cardiology 2003, 91:7-11.
14. Hsu S.P., Wu M.S., Yang C.C., Huang K.C., Liou S.Y., Hsu S.M., Chien C.T. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. American Journal of Clinical Nutrition 2007, 86:1539-1547.
15. Kovesdy C.P., Kalantar-Kadeh K. Novel targets and new potential developments in the treatment of inflammation in chronic kidney disease. Expert Opinion on Investigational Drugs 2008, 17:451-467.
16. Locatelli F., Canaud B., Eckardt K.U., Stenvinkel P., Wanner C., Zoccali C. Oxidative stress in end stage renal disease: An emerging threat to patient outcome. Nephrology Dialysis and Transplantation 2003, 18:1272-1280.
17. Luke R.G. Chronic renal failure-a vasculopathic state. New England Journal of Medicine 1998, 339:841-843.
18. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., Coresh J., Levey A.S., Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. Journal of the American College of Cardiology 2003, 41:47-55.
19. Menon V., Greene T., Wang X., Pereira A.A., Marcovina S.M., Beck G.J., Kusek J.W., Collins A.J., Levey A.S., Sarnak M.J. C-reactive protein and albumin as predictors for all cause and cardiovascular mortality in chronic kidney disease. Kidney International 2005, 68:766-772.
20. Merino A., Nogueras S., Buendia P., Ojeda R., Carracedo J., Ramirez-Chamond R., Martin-Malo A., Aljama P. Micro inflammation and endothelial damage in hemodialysis. Contribution to Nephrology 2008, 161:83-88.
21. Nantz M.P., Rowe C.A., Bukowski J.F., Percival S.S. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009, 25:147-154.
22. Park C.S., Kim W., Woo J.S., Ha S.J., Kang W.Y., Hwang S.H., Park Y.W., Kim Y.S., Ahn Y.K., Jeong M.H., Kim W. Green tea consumption improves endothelial function but not circulating endothelial progenitor cells in patients with chronic renal failure. International Journal of Cardiology 2010, 145:261-262.
23. Sagripanti A., Cupisti A., Baicchi U., Ferdeghini M., Morelli E., Barsotti G. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993, 63:273-278.
24. Shlipak M.G., Fried L.F., Cushman M., Manolio T.A., Peterson D., Stehman-Breen C., Bleyer A., Newman A., Siscovick D., Psaty B. Cardiovascular mortality risk in chronic kidney disease. JAMA 2005, 293:1737-1745.
25. Stenvinkel P., Heinburger O., Paultre F., Diczfalusy U., Wang T., Berglund L., Jogestrand T. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney International 1999, 55:1899-1911.
26. Tomura S., Nakamura Y., Deguchi F., Ando R., Chida Y., Marumo F. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thrombosis Research 1991, 64:81-90.
27. Undas A., Kolarz M., Kopeć G., Tracz W. Altered fibrin clot properties in patients on long-term haemodialysis: Relation to cardiovascular mortality. Nephrology Dialysis and Transplantation 2008, 23:2010-2015.
28. Weiner D.E., Thigionart H., Elsayed E.F., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. Inflammation and cardiovascular events in individuals with or without chronic kidney disease. Kidney International 2008, 73:1406-1412.
29. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. Journal of the American Society of Nephrology 2004, 15:1307-1315.
30. Zhong Y., Ma C., Shahidi F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. Journal of Functional Foods 2012, 4:87-93.
31. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 1999, 55:648-658.
32. Zoccali C., Mallamaci F., Tripepi G., Cutrupi S., Parlongo S., Malatino L.S., Bonanno G., Rapisarda F., Fatuzzo P., Seminara G., Stancanelli B., Nicocia G., Buemi M. Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. Journal of Internal Medicine 2003, 254:132-139.